Barbra Keck
Vermögen: 30 $ am 31.05.2026
Vermögen: 30 $ am 31.05.2026
Barbra C.
Keck is currently Director at SmartKem Ltd. and Chief Financial & Accounting Officer at SmartKem, Inc. since 2023.
Former positions include Chief Financial & Accounting Officer and Secretary at Delcath Systems, Inc. from 2017 to 2020, Chief Financial Officer at Deverra Therapeutics, Inc. from 2021 to 2022, Dean at Zicklin School of Business from 2006 to 2008, Manager-Donor Relations & Communications at Young Audiences New York from 2005 to 2006, Manager-Arts Series at the University of Dayton from 2002 to 2005, Director-Teacher Programs at Muse Machine from 2002 to 2003, General Manager at Bach Society of Dayton, Inc. from 1999 to 2002, and Audit Assistant & Member-Auditing Practice at Deloitte & Touche LLP in 2008.
Education includes undergraduate studies at the University of Dayton and an MBA from Baruch College.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.05.2026 | 100 ( 0 % ) | 30 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| SMARTKEM, INC. | Finanzdirektor/CFO | 14.12.2022 |
SmartKem Ltd.
SmartKem Ltd. Industrial SpecialtiesProcess Industries Develops and markets printable electronics and semiconductors | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
Deverra Therapeutics, Inc.
Deverra Therapeutics, Inc. BiotechnologyHealth Technology Develops off-the-shelf allogeneic cellular immunotherapies | Finanzdirektor/CFO | 01.12.2022 |
| DELCATH SYSTEMS, INC. | Finanzdirektor/CFO | 01.05.2020 |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services | Corporate Officer/Principal | 04.12.2008 |
Zicklin School of Business
Zicklin School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.08.2008 |
Young Audiences New York
Young Audiences New York Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization that offers education, culture and arts | Public Communications Contact | 01.05.2006 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 11 |
|---|---|
Delcath Systems, Inc.
Delcath Systems, Inc. Medical SpecialtiesHealth Technology Develops and manufactures drugs for treatment of cancer | Health Technology |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services | Commercial Services |
University of Dayton
University of Dayton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baruch College
Baruch College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bach Society of Dayton, Inc.
Bach Society of Dayton, Inc. Miscellaneous Commercial ServicesCommercial Services Performs and conducts music concerts | Commercial Services |
SmartKem Ltd.
SmartKem Ltd. Industrial SpecialtiesProcess Industries Develops and markets printable electronics and semiconductors | Process Industries |
Young Audiences New York
Young Audiences New York Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization that offers education, culture and arts | Commercial Services |
Zicklin School of Business
Zicklin School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Muse Machine
Muse Machine Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit arts education organization | Commercial Services |
SmartKem, Inc.
SmartKem, Inc. SemiconductorsElectronic Technology Engages in the development of materials and processes used to make organic thin-film transistors | Electronic Technology |
Deverra Therapeutics, Inc.
Deverra Therapeutics, Inc. BiotechnologyHealth Technology Develops off-the-shelf allogeneic cellular immunotherapies | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen